The study, published Oct. 20, looked at the transcutaneous laryngeal ultrasonography tool compared to a laryngoscopy.
The TLUSG’s performance in assessing vocal fold mobility was about 80 to 93 percent comparable to a laryngoscopy across four areas. Thirty-eight patients were observed in the study, some with normal vocal folds and others with unilateral vocal fold paralysis.
A TLUSG can’t replace a laryngoscopy, the study said. However, it’s a strong noninvasive tool for diagnostics during the COVID-19 pandemic.
Read and download the study here.
More articles on surgery centers:
What keeps otolaryngologists up at night: 6 perspectives
Viewpoint: An otolaryngologist’s perspective on COVID-19
Top priorities for ASC leaders today and in 2021: 7 key trends
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
